Preservation of DNA Privacy During the Large Scale Detection of COVID-19

As humanity struggles to contain the global COVID-19 pandemic, privacy concerns are emerging regarding confinement, tracing and testing. The scientific debate concerning privacy of the COVID-19 tracing efforts has been intense, especially focusing on the choice between centralised and decentralised tracing apps. The privacy concerns regarding COVID-19 testing, however, have not received as much attention even though the privacy at stake is arguably even higher. COVID-19 tests require the collection of samples. Those samples possibly contain viral material but inevitably also human DNA. Patient DNA is not necessary for the test but it is technically impossible to avoid collecting it. The unlawful preservation, or misuse, of such samples at a massive scale may hence disclose patient DNA information with far-reaching privacy consequences. Inspired by the cryptographic concept of "Indistinguishability under Chosen Plaintext Attack", this paper poses the blueprint of novel types of tests allowing to detect viral presence without leaving persisting traces of the patient's DNA. Authors are listed in alphabetical order.

[1]  Peter Eaton,et al.  Gold nanoparticles for the development of clinical diagnosis methods , 2008, Analytical and bioanalytical chemistry.

[2]  S. Nelson,et al.  Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays , 2008, PLoS genetics.

[3]  Sook-Kyung Kim,et al.  Quantification of Trace-Level DNA by Real-Time Whole Genome Amplification , 2011, PloS one.

[4]  C. Mirkin,et al.  A gold-nanoparticle-based real-time colorimetric screening method for endonuclease activity and inhibition. , 2007, Angewandte Chemie.

[5]  Matthew Osborne,et al.  Diagnosing COVID-19: The Disease and Tools for Detection , 2020, ACS nano.

[6]  NationalResearchCouncil,et al.  A Strategy for Research in Space Biology and Medicine in the New Century , 1998 .

[7]  Anne Cambon-Thomsen,et al.  The social and ethical issues of post-genomic human biobanks , 2004, Nature Reviews Genetics.

[8]  Marco Capocasa,et al.  Samples and data accessibility in research biobanks: an explorative survey , 2016, PeerJ.

[9]  Timothy Caulfield,et al.  Biobanks, consent and claims of consensus , 2012, Nature Methods.

[10]  Bradley Malin,et al.  Re-identification of DNA through an automated linkage process , 2001, AMIA.

[11]  L. Kaminsky,et al.  Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. , 1996, BioTechniques.

[12]  Christian Drosten,et al.  Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020, bioRxiv.

[13]  Z. Tong,et al.  Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak , 2020, Journal of medical virology.

[14]  M. Calnan,et al.  Trust relations in health care--the new agenda. , 2006, European journal of public health.

[15]  Duncan Taylor,et al.  Interpreting forensic DNA profiling evidence without specifying the number of contributors. , 2014, Forensic science international. Genetics.

[16]  小林 利彦,et al.  ビジネスモデル : CentralizedかDecentralizedか(オピニオン) , 2002 .

[17]  D. Pang,et al.  Colorimetric and visual determination of DNase I activity using gold nanoparticles as an indicator , 2016, Microchimica Acta.

[18]  Shinobu Sato,et al.  Highly Sensitive Nuclease Assays Based on Chemically Modified DNA or RNA , 2014, Sensors.

[19]  Bradley Malin,et al.  Determining the identifiability of DNA database entries , 2000, AMIA.

[20]  R. Swennen,et al.  Irreversible heat inactivation of DNase I without RNA degradation. , 2000, BioTechniques.

[21]  Xiaocui Zhu,et al.  Simultaneous fluorescence imaging of the activities of DNases and 3' exonucleases in living cells with chimeric oligonucleotide probes. , 2013, Analytical chemistry.

[22]  Manfred Kayser,et al.  Improving human forensics through advances in genetics, genomics and molecular biology , 2011, Nature Reviews Genetics.

[23]  S. Davis,et al.  The Unprecedented Stock Market Reaction to COVID-19 , 2020, Review of Asset Pricing Studies.

[24]  Yaniv Erlich,et al.  Rapid re-identification of human samples using portable DNA sequencing , 2017, eLife.

[25]  Cynthia Liu,et al.  Assay Techniques and Test Development for COVID-19 Diagnosis , 2020, ACS central science.